The Institutional Biological & Chemical (IBC) Safety Committee is responsible for ensuring that research carried out at WUSTL is conducted in a safe and responsible manner. The IBC oversees research involving recombinant DNA, infectious or potentially infectious agents, and/or hazardous chemicals.
The Cyclotron Safety Subcommitteemeets several times a year to review radiation safety matters associated with the use of the four particle accelerators used for the on-site production of radioactive materials.
The ICP Subcommittee meets regularly to review radiation safety matters associated with the use of category 1 and category 2 quantities of radioactive materials.
The Radioactive Drug Research Committeehas authority over human research involving radioactive drugs. Please contact Yara Holt (314-362-2810 or email@example.com) for further information on RDRC submissions.